Amla extract for transdermal application
OwnerBenny Antonyinventor
Life of this patent
Estimating the term…
Abstract
An extract of Emblica officinalis (Amla). Transdermal formulation having an extract of Emblica officinalis having exhibiting greater migration of Vitamin C across a skin surface as compared to a transdermal formulation having Vitamin C without the extract. Extract of Emblica officinalis exhibiting greater migration of H+ ions across a skin surface as compared to a transdermal formulation having Vitamin C alone. A transdermal formulation having an extract of Emblica officinalis. Method of preparing an extract of Emblica officinalis.
Claims4
A method of increasing transfer of Vitamin C across a skin surface of a subject in need thereof, the method comprising, administering a transdermal formulation comprising an extract Emblica officinalis fruit,
- wherein the extract of Emblica officinalis fruit comprises, by weight,
- about 35±5% of of galloellagitannin;
- about 1-9% of Vitamin C;
- and,
- about 5-60 of carbohydrate,
- wherein about 0.5-5% of the galloellagitannin is comprised of corilagin,
- wherein about 2-25 % of the carbohydrate is comprised of soluble fiber, and
- wherein the extract of Emblica officinalis fruit is prepared by a process comprising:
- pulping fruits of Emblica officinalis in water to obtain a slurry,
- centrifuging the slurry to obtain a supernatant,
- passing the supernatant through a strong H+ ion exchange resin to obtain a permeate, wherein the permeate is said extract of Emblica officinalis.
A method of increasing transfer of H+ ion across a skin surface of a subject in need thereof, the method comprising, administering a transdermal formulation comprising an extract of Emblica officinalis fruit, wherein the extract of Emblica officinalis fruit comprises, by weight,
- about 35±5% of galloellagitannin;
- about 1-9% of Vitamin C;
- and,
- about 5-60% of carbohydrate,
- wherein about 0.5-5% of the galloellgitannin is comprised of corilagin,
- wherein about 2-25% of the carbohydrate is comprised of soluble fiber, and
- wherein the extract of Emblica officinalis fruit is prepared by a process comprising;
- pulping fruits of Emblica officinalis in water to obtain a slurry,
- centrifuging the slurry to obtain a supernatant,
- passing the supernatant through a strong H+ ion exchange resin to obtain a permeate, wherein the permeate is said extract of Emblica officinalis.
A method of increasing transfer of Vitamin C across a skin surface of a subject in need thereof, the method comprising administering a transdermal formulation comprising an extract of Emblica officinalis fruit wherein the extract of Emblica officinalis fruit comprises, by weight,
- about 35-50% polyphenol, and wherein about 0.5-5% of the polyphenol is comprised of corilagin, and
- wherein the extract of Emblica officinalis fruit is prepared by a process comprising;
- pulping fruits of Emblica officinalis in water to obtain a slurry,
- centrifuging the slurry to obtain a supernatant,
- passing the supernatant through a strong H+ ion exchange resin to obtain a permeate, wherein the permeate is said extract of Emblica officinalis.
A method of increasing transfer of H+ ion across a skin surface of a subject in need thereof, the method comprising administering a transdermal formulation comprising an extract of Emblica officinalis fruit,
- wherein the extract of Emblica officinalis fruit comprises, by weight,
- about 35-50% and wherein about 0.5-5% of the polyphenol is comprised of corilagin, and
- wherein the extract of Emblica officinalis fruit is prepared by a process comprising:
- pulping fruits of Emblica officinalis in water to obtain a slurry,
- centrifuging the slurry to obtain a supernatant,
- passing the supernatant through a strong H+ ion exchange resin to obtain a permeate, wherein the permeate is said extract of Emblica officinalis .
Dependencies are inferred from the claim text.